Why United States Antimony (UAMY) Is Down 14.0% After Cutting Guidance On Weaker Antimony Prices

United States Antimony

United States Antimony

UAMY

0.00

  • United States Antimony Corporation reported its second-quarter 2026 results in the past, with sales falling to US$7.93 million from US$10.53 million a year earlier and net income easing to about US$0.11 million.
  • For the first half of 2026, the company swung from a small profit to an US$11.18 million net loss as weaker antimony prices hit revenue and earnings, prompting a sharply reduced full-year sales outlook.
  • We’ll now examine how the guidance cut linked to weaker antimony pricing reshapes United States Antimony’s investment narrative for investors.

Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

What Is United States Antimony's Investment Narrative?

To own United States Antimony today, you really have to believe in its role as a domestic antimony and specialty minerals supplier, despite the current earnings setback. The sharp guidance cut to US$60–75 million of 2026 revenue, driven by weaker antimony pricing, directly affects what had been a key near term catalyst: rapid top-line growth off supply agreements and government-related demand. The Q2 numbers confirm that pricing, not volumes, is the problem, which pulls more attention to two immediate risks: margin pressure and a cash runway of less than a year. On the other hand, the Defense Logistics Agency contract, the Idaho processing JV and growing zeolite revenue still underpin the core thesis, but investors now have to factor in higher execution risk and greater sensitivity to commodity prices in the months ahead.

However, short cash runway and ongoing losses are information investors should be aware of. Despite retreating, United States Antimony's shares might still be trading 15% above their fair value. Discover the potential downside here.

Exploring Other Perspectives

UAMY Earnings & Revenue Growth as at Aug 2026
UAMY Earnings & Revenue Growth as at Aug 2026
Fifteen Simply Wall St Community fair value estimates span roughly US$1 to US$41, showing very different views on UAMY. Set that against the recent guidance cut and compressed margins, and you can see why opinions on the company’s path from loss making to self funded growth are so far apart.

Explore 15 other fair value estimates on United States Antimony - why the stock might be worth less than half the current price!

The Verdict Is Yours

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your United States Antimony research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.

Searching For A Fresh Perspective?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.